A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

The Elizabeth Glaser Pediatric AIDS Foundation said the latest cuts will deprive 350,000 people of HIV treatment.

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Your treatment and how successful it is depends ... You might bruise or bleed easily. And if you have HIV, you'll be at an even greater risk of infection because your white blood cell count ...

Majola is one of millions of patients in South Africa affected by President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection rates ...